Article Details
Retrieved on: 2022-08-18 01:51:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
2022-08-17 | NDAQ:KRBP) HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Kiromic BioPharma, Inc. (KRBP) with Significant Losses to ...
Article found on: stockhouse.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here